Is T-wave alternans as good or better than programmed ventricular stimulation?

Heart Rhythm

Volumn 4, Issue 7, 2007, Pages 913-915

  Narayan, Sanjiv M ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIOMYOPATHY; DEFIBRILLATOR; EDITORIAL; ELECTROCARDIOGRAPHY; EXERCISE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART STIMULATION; HEART VENTRICLE ARRHYTHMIA; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL; T WAVE;

CARDIAC PACING, ARTIFICIAL; HUMANS; TACHYCARDIA, VENTRICULAR;

EID: 34250727597     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.03.014     Document Type: Editorial

References (29)

1. Myerburg R.J., and Castellanos A. Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm 3 (2006) 235-239
2. Verma A., Kilicaslan F., Martin D., Minor S., Starling R., Marrouche N., Almahammed S., Wazni O., Duggal S., Zuzek R., Yamaji H., Cummings J., Chung M., Tchou P., and Natale A. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Heart 92 (2006) 190-195
3. Zipes D., and Rubart M. Neural modulation of cardiac arrhythmias and sudden cardiac death. Heart Rhythm 3 (2005) 108-113
4. Assomull R., Prasad S., Lyne J., Smith G., Burman E., Khan M., Sheppard M., Poole-Wilson P., and Pennell D. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1977-1985
5. Buxton A.E., Lee K.L., Hafley G.E., Wyse D.G., Fisher J.D., Lehmann M.H., Pires L.A., Gold M.R., Packer D.L., Josephson M.E., Prystowsky E.N., Talajic M.R., and MUSTT Investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial. Circulation 106 (2002) 2466-2472
6. Buxton A.E., Lee K.L., Carlo L.D., Gold M.R., Greer G.S., Prystowsky E.N., O'Toole M.F., Tang A., Fisher J.D., Coromilas J., Talajic M., Hafley G., and Multicenter Unsustained Tachycardia Trial Investigators (MUSTT). Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 342 (2000) 1937-1945
7. Rashba E., Estes N., Wang P., Schaechter A., Howard A., Zareba W., Couderc J., Perkiomaki J., Levine J., and Kadish A. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Heart Rhythm 3 (2006) 281-286
8. Gomes J.A., Cain M.E., Buxton A.E., Josephson M.E., Lee K.L., and Hafley G.E. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 104 (2001) 436-441
9. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L., and Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
10. Buxton A.E., Sweeney M.O., Wathen M.S., Josephson M.E., Otterness M.F., Hogan-Miller E., Stark A.J., DeGroot P.J., and PainFREE Rx II Investigators. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol 46 (2005) 310-316
11. Walker M.L., and Rosenbaum D.S. Cellular alternans as mechanism of cardiac arrhythmogenesis. Heart Rhythm 2 (2005) 1383-1386
12. Weiss J.N., Karma A., Shiferaw Y., Chen P.-S., Garfinkel A., and Qu Z. From pulsus to pulseless: the saga of cardiac alternans (review). Circ Res 98 (2006) 1244
13. Narayan S.M. T-Wave alternans and the susceptibility to ventricular arrhythmias: state of the art paper. J Am Coll Cardiol 47 (2006) 269-281
14. Chow T., Kereiakes D., Bartone C., Booth T., Schloss E., Waller T., Chung E., Menon S., Nallamothu B., and Chan P. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 49 (2007) 50-58
15. ACC/AHA/ESC. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death-Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006) 1064-1108
16. Gold M.R., Chilson D., Ip J.H., Costantini O., Bloomfield D., Poole J., McNulty S., Lee K., and Bardy G. T-wave alternans SCD-HeFT Study: primary endpoint analysis (abstr). Circulation 114 (2006) 2113
17. Morin D.P., Zacks E.S., Mauer A.C., Ageno S., Janik M., Markowitz S.M., Mittal S., Iwai S., Shah B.K., Lerman B.B., and Stein K.M. Effect of bundle branch block on microvolt T-wave alternans and electrophysiologic testing in patients with ischemic cardiomyopathy. Heart Rhythm 4 (2007) 904-912
18. Costantini O., Rosenbaum D.S., Hohnloser S.H., Kirk M., Lerman B., Baker J.I., Sethuraman B., and Dettmer M. The Alternans Before Cardioverter Defibrillator (ABCD) trial: a noninvasive strategy for primary prevention of sudden cardiac death using T wave alternans (abstr). Late Breaking Clinical Trials III. Circulation 114 (2006) 2426
19. Rashba E.J., Osman A.F., MacMurdy K., Kirk M.M., Sarang S.E., Peters R.W., Shorofsky S.R., and Gold M.R. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation:. a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol 15 (2004) 170-176
20. Gold M.R., Bloomfield D.M., Anderson K.P., El-Sherif N., Wilber D.J., Groh W.J., Estes N.A.M., Kaufman E.S., Greenberg M.L., and Rosenbaum D.S. A comparison of T wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36 (2000) 2247-2253
21. Bloomfield D.M., Bigger J.T., Steinman R.C., Namerow P.B., Parides M.K., Curtis A.B., Kaufman E.S., Davidenko J.M., Shinn T.S., and Fontaine J.M. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
22. Rashba E.J., Osman A.F., MacMurdy K., Kirk M.M., Sarang S., Peters R.W., Shorofsky S.R., and Gold M.R. Influence of QRS duration on the prognostic value of T wave alternans. J. Cardiovasc Electrophysiol 13 (2002) 770-775
23. Narayan S.M., Smith J.M., Schechtman K.B., Lindsay B.D., and Cain M.E. T-wave alternans phase following ventricular extrasystoles predicts arrhythmia-free survival. Heart Rhythm 2 (2005) 234-241
24. Rashba E.J. Should T-wave alternans testing be used to risk stratify candidates for prophylactic implantable cardioverter-defibrillator therapy?. Heart Rhythm 2 (2005) 242-244
25. Raatikainen M., Jokinen V., Virtanen V., Hartikainen J., Hedman A., Huikuri H., and Investigators C. Microvolt T-wave alternans during exercise and pacing in patients with acute myocardial infarction. Pacing Clin Electrophysiol 28 (2005) S193-S197
26. Shalaby A., Voigt A., El-Saed A., Mains M., and Shusterman V. Microvolt T-wave alternans during atrial and ventricular pacing. Pacing Clin Electrophysiol 30 (2007) S178-S182
27. Cox V.L., Patel M., Kim J., Liu T., Sivaraman G., and Narayan S.M. Predicting arrhythmia-free survival using spectral and modified-moving average analyses of T-wave alternans. Pacing Clin Electrophysiol 30 (2007) 352-358
28. Rashba E.J., Osman A.F., MacMurdy K., Kirk M.M., Sarang S., Peters R.W., Shorofsky S.R., and Gold M.R. Exercise is superior to pacing for the measurement of T-wave alternans. J Cardiovasc Electrophysiol 13 (2002) 845-850
29. Gehi A.K., Stein R.H., Metz L.D., and Gomes J.A. Microvolt T-wave alternans for risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46 (2005) 75-82